2010³â 12¿ù30ÀÏ ½ÉÀåÇ÷°ü°è ÀÌÁ¾Á¶Á÷°³¹ß ½ê¹Ì³ª¸¦ °³ÃÖÇÏ¿´´Ù.
Àå¼Ò´Â ¼¿ï ½ÅÃÌ ¿¬¼¼´ëÇб³ µ¿Ã¢È¸°ü³» Ƽ¿ø Áß±¹½Ä´ç¿¡¼ ¿ÀÈÄ 4~7½Ã±îÁö ÁøÇàÇÏ¿´´Ù.
Âü¼®ÀÚ´Â ¸ðµç ¿¬±¸¿ø, Å¿õ¿¬±¸¿ø, ¿¡µå¿öµå, Áß±¹ÀÇ»çºÐµé·Î ¸¹Àº Âü¼®ÀÌ ÀÖ¾úÀ¸¸ç 2010³âÀ» ¸¶¹«¸®ÇÏ´Â ½Éµµ³ôÀº ÅäÀÇ¿Í 2011³âµµÀÇ
¿¬±¸¿¡´ëÇÑ °èȹ¹ßÇ¥°¡ ÀÖ¾ú´Ù.
ÀÌ ¹ø ½ê¹Ì³ª¿¡¼ ¹ßÇ¥µÈ ³»¿ëÀº ´ÙÀ½°ú °°¾Ò´Ù.
±è¿ëÁø
Overview
of xenograft
preservation
¹Úõ¼ö
Xeno-reactive
antibody in tissue valve implantation
ÀÓÈ«±¹
2010³â
½ÇÇè °á°ú ºÐ¼®
È«°¼±
ÆǸ· µðÀÚÀΰú
strut Á¦Á¶¹®Á¦Á¡
¹× ÀÌÁ¾Àå±â¿¡ °üÇÑ ½Ä¾àû
µî·Ï
ÃÖ¼±¿µ
»ç¶÷°ú
µ¿¹°½ÇÇè¿¡¼ÀÇ
ELISA Test ºÐ¼®
°ú ¹®Á¦Á¡
À±ÀºÁ¤
Electrophoresis application in decellularization
& effect of
double crosslinking
& filler
±è¼öȯ
Photo-oxidation
& use of UV light in crosslinking
ÀÌâÇÏ
Valved
conduit & pericardial valve design
ÀÓ Ã»
Overview
& experiment of percutaneous
stented
valve
¿À»ï¼¼
Transcatheter
AVRÀÇ
½ÇÁ¦
|